Illumina is the leading sequencing platform in the next-generation ... United States), followed by A-tailing, adapter ligation and PCR amplification. DNA library quality was assessed using a Qubit and ...

Equimolar Adapter 1 and Adapter 2 were added after transposition and ... The library preparations were sequenced after cluster generation on an Illumina Hiseq platform and 150 bp paired-end reads were ...

Illumina is down 15.2% since the beginning of the year, and at $111.06 per share, it is trading 28.4% below its 52-week high of $155.15 from November 2024. Investors who bought $1,000 worth of ...

Illumina has struggled to boost sales and consistently deliver positive earnings. Its Q4 report was largely a disappointment, and management's 2025 guidance came in below Wall Street's ...

China's "blacklist of entities" now has two more entries -- Illumina and fashion conglomerate PVH-- after its government put the companies on notice late Monday. The move is clearly a retaliatory ...

(RTTNews) - Below are the earnings highlights for Illumina Inc. (ILMN): Earnings: $187 million in Q4 vs. -$176 million in the same period last year. EPS: $1.17 in Q4 vs. -$1.11 in the same period ...

(Reuters) -Shares of genetic testing company Illumina and Calvin Klein-owner PVH Corp fell on Tuesday after China placed the two companies on its "unreliable entity" list, putting them at risk of ...

Shares of gene-sequencing leader Illumina have fallen 15% from Friday. Rivals 10X Genomics and Pacific BioSciences of California lost 18% and 15%, respectively. We recently published a list of Jim ...

China’s Ministry of Commerce on Tuesday added Illumina, a maker of DNA sequencing systems, to its unreliable entity list as trade tensions with the U.S. flared. Listing Illumina as an untrustworthy ...